Case T-175/22: Judgment of the General Court of 15 March 2023 — Novartis v EUIPO — AstraZeneca (BREZTRI) (EU trade mark — Invalidity proceedings — EU word mark BREZTRI — Earlier EU word marks ONBREZ, BREZILIZER and BREEZHALER — No likelihood of confusion — Lack of enhanced distinctiveness of the earlier marks — Article 60(1)(a) and Article 8(1)(b) of Regulation (EU) 2017/1001 — Article 27(3)(b) of Regulation (EU) 2018/625)